| ID Source | ID |
|---|---|
| PubMed CID | 6327365 |
| MeSH ID | M0498552 |
| Synonym |
|---|
| AKOS015840147 |
| 1,1,1,3,3,3-hexamethyl-2-(trimethylsilyl)trisilane |
| tris(trimethylsilyl)silane , |
| tris(trimethylsilyl)silane, 97% |
| T1463 |
| tris(trimethylsilyl)silicon |
| 1,1,1,3,3,3-hexamethyl-2-trimethylsilyl-trisilane |
| A813142 |
| FT-0649668 |
| S21375 |
| tris(trimehylsilyl)silane |
| tris(trimethylsilyl)silane [mi] |
| 1,1,1,3,3,3-hexamethyl-2-(trimethylsilyl)trisilane # |
| J-012060 |
| DTXSID70940202 |
| FS-4864 |
| AMY42289 |
| tris(trimethylsilyl)silane [reducing reagent] |
| EN300-7384553 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.16) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||